Your prediction
Pros and Cons of Eagle Pharmaceuticals Inc in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Eagle Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | 0.230% | 15.831% | 8.328% | -45.601% | 29.786% | -28.618% | -93.293% |
| Pacira Pharmaceuticals | 0.000% | -3.960% | -1.523% | -11.009% | -10.185% | -46.111% | -65.965% |
| Twist Bioscience Corp | -6.550% | -4.060% | -11.696% | -6.090% | 30.664% | 135.412% | -66.615% |
Comments
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Show more
Ratings data for EGRX provided by MarketBeat
